| 中国学者近期发表的论文 |
|---|
| 1. | Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma.
Author: Guo XL, Li D, Sun K, Wang J, Liu Y, Song JR, Zhao QD, Zhang SS, Deng WJ, Zhao X, Wu MC, Wei LX.
Journal: J Mol Med (Berl). 2013 Apr;91(4):473-83. doi: 10.1007/s00109-012-0966-0. Epub 2012 Oct 10. | | 2. |
Author:
Journal: | | 3. | Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice.
Author: Chen J, Duan L, Xiong A, Zhang H, Zheng F, Tan Z, Gong F, Fang M.
Journal: J Mol Med (Berl). 2012 Dec;90(12):1505-15. doi: 10.1007/s00109-012-0938-4. Epub 2012 Sep 16. | | 4. | Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
Author: Zhuang H, Jiang W, Zhang X, Qiu F, Gan Z, Cheng W, Zhang J, Guan S, Tang B, Huang Q, Wu X, Huang X, Jiang W, Hu Q, Lu M, Hua ZC.
Journal: J Mol Med (Berl). 2013 Feb;91(2):219-35. doi: 10.1007/s00109-012-0947-3. Epub 2012 Sep 5. | | 5. | Functionalized single-walled carbon nanotubes cause reversible acute lung injury and induce fibrosis in mice.
Author: Zhang Y, Deng J, Zhang Y, Guo F, Li C, Zou Z, Xi W, Tang J, Sun Y, Yang P, Han Z, Li D, Jiang C.
Journal: J Mol Med (Berl). 2013 Jan;91(1):117-28. doi: 10.1007/s00109-012-0940-x. Epub 2012 Aug 10. | | 6. | Exon 47 skipping of fibrillin-1 leads preferentially to cardiovascular defects in patients with thoracic aortic aneurysms and dissections.
Author: Wang WJ, Han P, Zheng J, Hu FY, Zhu Y, Xie JS, Guo J, Zhang Z, Dong J, Zheng GY, Cao H, Liu TS, Fu Q, Sun L, Yang BB, Tian XL.
Journal: J Mol Med (Berl). 2013 Jan;91(1):37-47. doi: 10.1007/s00109-012-0931-y. Epub 2012 Jul 8. | | 7. | Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells.
Author: Feng L, Pan M, Sun J, Lu H, Shen Q, Zhang S, Jiang T, Liu L, Jin W, Chen Y, Wang X, Jin H.
Journal: J Mol Med (Berl). 2013 Jan;91(1):49-58. doi: 10.1007/s00109-012-0932-x. Epub 2012 Jul 5. | | 8. | Genetic variation in the Nrf2 promoter associates with defective spermatogenesis in humans.
Author: Yu B, Lin H, Yang L, Chen K, Luo H, Liu J, Gao X, Xia X, Huang Z.
Journal: J Mol Med (Berl). 2012 Nov;90(11):1333-42. doi: 10.1007/s00109-012-0914-z. Epub 2012 May 31. | | 9. | Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling.
Author: Chen X, Wu Y, Jiang Y, Zhou Y, Wang Y, Yao Y, Yi C, Gou L, Yang J.
Journal: J Mol Med (Berl). 2012 Nov;90(11):1311-9. doi: 10.1007/s00109-012-0910-3. Epub 2012 May 31. | | 10. | Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.
Author: Ren S, Xu C, Cui Z, Yu Y, Xu W, Wang F, Lu J, Wei M, Lu X, Gao X, Liang Y, Mao JH, Sun Y.
Journal: J Mol Med (Berl). 2012 Oct;90(10):1121-32. doi: 10.1007/s00109-012-0885-0. Epub 2012 Mar 16. |
|
